Krka sets up joint venture with Chinese partner
Novo Mesto, 18 November - The Novo mesto-based pharma company Krka and its Chinese partner Ningbo Menovo Pharmaceutical have set up a joint venture Ningbo Krka Menovo Pharmaceutical. Krka holds a 60% stake in the new company. Its initial capital will total EUR 30m and it will be led by a three-member board of directors.
The rest of this news item is available to subscribers.
The news item consists of 1.142 characters (without spaces) or 211 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.